Venetoclax as cytoreductive therapy in high-risk acute promyelocytic leukemia: A potential alternative to anthracyclines.

Authors: Ravi Teja Banda, Attili Venkata Satya Suresh, Pradeep Reddy

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.6521

Source: Full article

---

Abstract

6521